Nationwide shortages. Off-label use. Filled without an office visit. Billions in savings for insurers. David Johnson and Julie Murchinson give you their take on the GLP-1 weight loss drug market frenzy on this special episode of the 4sight Health Roundup podcast moderated by David Burda.

David W. Johnson is CEO of 4sight Health.

Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution.

David Burda is News Editor and Columnist of 4sight Health.

To bring your own revolutionary ideas to life, sponsor this podcast. Email ⁠⁠⁠⁠⁠⁠⁠⁠[email protected]⁠⁠⁠⁠⁠⁠⁠⁠ for more.

Listen on your podcast app or on the ⁠⁠⁠⁠⁠⁠⁠4sight Health YouTube Channel⁠⁠⁠⁠⁠⁠⁠.

Subscribe on ⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠Google Podcasts⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠.